Quality of Care for Women A Review of Selected Clinical Conditions and Quality Indicators

by McGlynn, Elizabeth A.; Kerr, Eve A.; Damberg, Cheryl L.; Asch, Steven M.

• ISBN13: 9780833029232
• ISBN10: 0833029231
• Edition: 1st
• Format: Paperback
• Copyright: 2000-12-19
• Publisher: RAND CORPORATION

Table of Contents

Preface	p. iii
Tables	p. xi
Acknowledgments	p. xiii
Introduction	p. 1
Advantages Of The QA Tools System	p. 1
Selecting Clinical Areas For The QA Tools	p. 3
Selecting Quality Indicators	p. 6
Literature Review	p. 6
Types of Indicators	p. 7
The Expert Panel Process	p. 8
Developing Quality Indicators For Women	p. 14
Selecting Clinical Areas	p. 15
Conducting Literature Reviews	p. 17
Developing Indicators	p. 18
Selecting Panel Participants	p. 19
Selecting the Final Indicators	p. 20
Analyzing The Final Indicators	p. 22
Conclusion	p. 24
Organization Of This Document	p. 25
References	p. 26
Acne	p. 29
Importance	p. 29
Efficacy and/or Effectiveness of Interventions	p. 29
Screening	p. 29
Diagnosis	p. 30
Treatment	p. 31
Follow-up	p. 33
Recommended Quality Indicators For Acne	p. 34
References - Acne	p. 36
Alcohol Dependence	p. 37
Importance	p. 37
Efficacy and/or Effectiveness of Interventions	p. 38
Screening	p. 38
Initial Evaluation	p. 39
Treatment	p. 39
Follow-up	p. 41
Recommended Quality Indicators For Alcohol Dependence	p. 42
References - Alcohol Dependence	p. 44
Allergic Rhinitis	p. 47
Importance	p. 47
Efficacy/Effectiveness of Interventions	p. 47
Diagnosis	p. 47
Treatment	p. 48
Recommended Quality Indicators For Allergic Rhinitis	p. 50
References - Allergic Rhinitis	p. 51
Asthma	p. 53
Importance	p. 53
Diagnosis	p. 54
Efficacy and/or Effectiveness of Interventions	p. 56
Patient Education	p. 56
Pharmacologic Therapy	p. 57
Diagnosis and Treatment of Allergic Asthma	p. 58
General Management Principles	p. 59
Chronic Mild Asthma	p. 59
Chronic Moderate Asthma	p. 59
Chronic Severe Asthma	p. 60
Other Management Measures	p. 60
Care of an Acute Asthma Exacerbation	p. 60
Care of Patients Hospitalized for Asthma	p. 62
Recommended Quality Indicators For Asthma	p. 64
References - Adult Asthma	p. 69
Breast Mass	p. 71
Importance	p. 71
Efficacy And/Or Effectiveness Of Interventions	p. 71
Recommended Quality Indicators For Breast Mass	p. 74
References - Breast Mass	p. 75
Cesarean Delivery	p. 77
Importance	p. 78
Prior Cesarean Delivery	p. 79
Importance	p. 79
Efficacy and/or Effectiveness of Interventions	p. 80
Treatment with Repeat Cesarean vs. Trial of Labor	p. 80
Recommended Quality Indicators For Prior Cesarean Delivery	p. 83
Cesarean Delivery for Failure to Progress in Labor	p. 85
Importance	p. 85
Efficacy and/or Effectiveness of Interventions	p. 85
Diagnosis	p. 85
Treatment	p. 87
Recommended Quality Indicators For Cesarean Delivery For Failure To Progress In Labor	p. 89
Fetal Distress/Non-reassuring Fetal Status and Intrapartum Fetal Heart Rate Monitoring	p. 91
Importance	p. 91
Efficacy and/or Effectiveness of Interventions	p. 91
Diagnosis	p. 91
Recommended Quality Indicators For Cesarean Delivery for Fetal Distress	p. 94
Prophylactic Antibiotics For Cesarean Delivery	p. 95
Importance	p. 95
Efficacy and/or Effectiveness of Interventions	p. 95
Prevention	p. 95
Recommended Quality Indicators For Antibiotic Prophylaxis for Cesarean Delivery	p. 98
References - Cesarean Delivery	p. 99
Cigarette Use Counseling	p. 103
Importance	p. 103
Efficacy and/or Effectiveness of Interventions	p. 104
Screening and Initial Evaluation	p. 104
Treatment and Prevention	p. 104
Follow-up	p. 106
Recommended Quality Indicators For Cigarette Use Counseling	p. 107
References - Cigarette Use Counseling	p. 109
Depression	p. 111
Importance	p. 111
Efficacy and/or Effectiveness of Interventions	p. 112
Screening/Detection	p. 112
Diagnosis	p. 114
Treatment	p. 115
Follow-up	p. 117
Recommended Quality Indicators For Depression	p. 119
References - Depression	p. 123
Diabetes Mellitus	p. 125
Importance	p. 125
Efficacy and/or Effectiveness of Interventions	p. 126
Screening	p. 126
Diagnosis	p. 126
Treatment	p. 129
Follow-up	p. 131
Recommended Quality Indicators For Diabetes Mellitus	p. 132
References - Diabetes	p. 135
Family Planning/Contraception	p. 139
Importance	p. 139
Efficacy of Intervention	p. 140
Screening for Risk of Unintended Pregnancy	p. 140
Treatment	p. 141
Recommended Quality Indicators For Family Planning/Contraception	p. 143
References - Family Planning/Contraception	p. 145
Headache	p. 147
Importance	p. 147
Efficacy and/or Effectiveness of Interventions	p. 147
Diagnosis	p. 147
Treatment	p. 149
Follow-up Care	p. 150
Recommended Quality Indicators For Headache	p. 152
References - Headache	p. 154
Hypertension	p. 157
Importance	p. 157
Efficacy and/or Effectiveness of Interventions	p. 158
Screening	p. 158
Initial Evaluation	p. 158
Treatment	p. 160
Follow-up	p. 162
Recommended Quality Indicators for Hypertension	p. 163
References - Hypertension	p. 167
Low Back Pain (Acute)	p. 171
Importance	p. 171
Efficacy and/or Effectiveness of Interventions	p. 173
Primary Prevention	p. 173
Diagnosis	p. 174
Treatment	p. 175
Recommended Quality Indicators For Acute Low Back Pain	p. 179
References - Low Back Pain	p. 183
Prenatal Care	p. 189
Importance	p. 190
Efficacy and/or Effectiveness of Interventions	p. 193
Timing and Frequency of Visits	p. 193
Gestational Age Determination	p. 194
Nutrition and Anemia	p. 195
Substance Abuse	p. 198
Infections and Sexually Transmitted Diseases	p. 204
Congenital Fetal Disorders	p. 211
Common Pregnancy Complications	p. 217
Recommended Quality Indicators For Prenatal Care	p. 225
References - Prenatal Care	p. 236
Preterm Labor, Corticosteroids For Fetal Maturation	p. 259
Importance	p. 259
Efficacy and/or Effectiveness of Interventions	p. 259
Recommended Quality Indicators For Corticosteroids For Fetal Maturation In Labor	p. 262
References - Corticosteroids For Fetal Maturation In Labor	p. 263
Preventive Care	p. 265
Immunizations	p. 266
Importance	p. 266
Tetanus	p. 266
Diphtheria	p. 267
Influenza	p. 267
Efficacy and/or Effectiveness of Interventions	p. 268
Sexually Transmitted Diseases and HIV Prevention	p. 268
Importance	p. 269
Efficacy and/or Effectiveness of Interventions	p. 269
Obesity Counseling	p. 271
Importance	p. 271
Efficacy and/or Effectiveness of Interventions	p. 272
Seat Belt Use Counseling	p. 273
Importance	p. 273
Efficacy and/or Effectiveness of Interventions	p. 274
Breast Examination	p. 275
Importance	p. 275
Efficacy and/or Effectiveness of Interventions	p. 275
Hyperlipidemia Screening	p. 278
Importance	p. 278
Efficacy and/or Effectiveness of Interventions	p. 278
Screening	p. 278
Efficacy of Early Treatment	p. 279
Recommendations	p. 280
Hypertension Screening	p. 281
Cervical Cancer Screening	p. 281
Importance	p. 281
Effectiveness of Interventions	p. 282
Screening	p. 282
Management of Women with Abnormal Pap Smears	p. 284
Recommended Quality Indicators For Routine Preventive Care	p. 286
References - Routine Preventive Care	p. 289
Upper Respiratory Infections	p. 295
Importance	p. 295
Pharyngitis, Acute	p. 296
Efficacy and/or Effectiveness of Interventions	p. 296
Diagnosis	p. 296
Treatment	p. 297
Follow-up	p. 298
Bronchitis, Acute	p. 298
Importance	p. 298
Efficacy and/or Effectiveness of Interventions	p. 298
Diagnosis	p. 298
Treatment	p. 299
Influenza	p. 299
Importance	p. 299
Efficacy and/or Effectiveness of Interventions	p. 300
Diagnosis	p. 300
Treatment	p. 300
Nasal Congestion and Rhinorrhea	p. 301
Importance	p. 301
Efficacy and/or Effectiveness of Interventions	p. 301
Diagnosis and Treatment	p. 301
Sinusitis	p. 302
Importance-Acute and Chronic Sinusitis	p. 302
Efficacy and/or Effectiveness of Interventions	p. 303
Acute Sinusitis	p. 303
Chronic Sinusitis	p. 304
Treatment	p. 304
Recommended Quality Indicators For Upper Respiratory Infections	p. 306
References - Upper Respiratory Infections	p. 310
Urinary Tract Infection	p. 313
Importance	p. 313
Efficacy and/or Effectiveness of Interventions	p. 313
Screening	p. 313
Diagnosis	p. 313
Treatment	p. 315
Follow-up	p. 316
Recommended Quality Indicators For Urinary Tract Infection	p. 318
References - Urinary Tract Infection	p. 322
Vaginitis and Sexually Transmitted Diseases, Diagnosis and Treatment	p. 325
Vulvovaginitis	p. 325
Importance	p. 325
Efficacy and/or Effectiveness of Interventions	p. 326
Screening	p. 326
Diagnosis	p. 326
Treatment	p. 328
Follow-up Care	p. 330
Diseases Characterized by Cervicitis	p. 330
Importance	p. 330
Efficacy and/or Effectiveness of Interventions	p. 331
Screening	p. 331
Diagnosis	p. 331
Treatment	p. 331
Follow-up Care	p. 333
Pelvic Inflammatory Disease (PID)	p. 333
Importance	p. 333
Efficacy/Effectiveness of Interventions	p. 333
Diagnosis	p. 333
Treatment	p. 334
Follow-up Care	p. 336
Diseases Characterized by Genital Ulcers	p. 336
Importance	p. 336
Efficacy and/or Effectiveness of Interventions	p. 336
Genital Herpes Simplex Infection	p. 336
Chancroid	p. 337
Primary and Secondary Syphilis	p. 338
Recommended Quality Indicators For Vaginitis And Sexually Transmitted Diseases	p. 340
References - Vaginitis And Sexually Transmitted Diseases	p. 345
Definitions for Indicator Tables	p. 347
Panel Ratings Sheets By Condition	p. 353
Crosswalk Table of Original and Final Indicators	p. 401
Table of Contents provided by Syndetics. All Rights Reserved.